Strong Progress and Financial Update from Celldex Therapeutics
August 8, 2025 - 01:36
Celldex Therapeutics has announced significant advancements in its pipeline, showcasing impressive results from its Phase 2 CSU study. The data revealed a profound and sustained complete response in patients, along with an improved quality of life measured seven months after the conclusion of barzolvolimab dosing. This breakthrough underscores the company's commitment to developing innovative therapies.
In addition to the CSU study results, Celldex is anticipating further data from ongoing Phase 2 studies of barzolvolimab targeting eosinophilic esophagitis (EoE) and chronic inducible urticaria (CIndU). Furthermore, results from a Phase 1 study of CDX-622 in healthy volunteers are expected in the latter half of 2025. These upcoming data releases are highly anticipated by stakeholders and could have significant implications for the company’s future direction and product offerings.
The financial results reported for the second quarter of 2025 reflect the company's strong execution and strategic focus on advancing its clinical programs, positioning it well for continued growth in the biopharmaceutical landscape.
MORE NEWS
April 7, 2026 - 00:24
Making Cents: Financial expert shares everyday habit to rethinkA leading financial expert is urging consumers to critically examine one of their most routine money habits: the use of digital payment apps and cards for daily, small purchases. While convenient,...
April 6, 2026 - 02:35
A Generational Investment Opportunity: 3 AI Stocks I'm Buying NowThe recent market volatility has created a compelling entry point for investors looking to build a position in the transformative field of artificial intelligence. Several industry-leading...
April 5, 2026 - 01:23
Isa savers under 65 have ‘last chance’ in the new 2026-27 tax yearThe approaching 2026-27 tax year represents a pivotal deadline for many UK savers. Individuals under the age of 65 are being alerted to a final chance to fully utilise the current annual Cash ISA...
April 4, 2026 - 17:14
Copper-Aluminum Divergence Unveils The Complex Iran War ImpactFour weeks into the ongoing Middle East conflict, a significant divergence has emerged between two key industrial metals: copper and aluminum. While both are sensitive to global economic sentiment,...